THE DRUGANALYST GLOBAL
Our quarterly workbook is released after each earnings season and sets out forecast expectations for the coming quarter.
It provides a top-down analysis of the global Pharma sector from macro trends to regional catalysts, therapeutic class developments to individual drugs, and a detailed review of each company ranging from numbers to newsflow, pipeline development to valuation, the risks and catalysts.
Brutally honest, truly independent analysis.
You need to read this before investing in the Pharma sector.
DrugAnalyst is the leading independent Pharmaceuticals Equity Research provider.
Global healthcare stock coverage and a database containing 10-years of drug sales forecasts
Drug sales forecasts are refreshed on a daily basis
The entire database is published once a quarter within our subscription only Global Pharma Workbook
Bespoke consensus can be processed based on your own research feeds
Our proprietary numbers form the basis of our BUY/SELL calls. We calculate the correlation coefficient for each number against the shareprice and use movements in those key lines to drive our calls. We are looking for increasing expectations into tightening errors (or vice versa). With a hurdle R2>0.9, the best thing is that it works!
Our proprietary numbers form the basis of our BUY/SELL calls
We offer to process your purchased research feeds into a bespoke consensus just for you.
This will be loaded daily into your online login. By this means you can still track your personal consensus using our established methodology, and continue to receive timely quarterly expectations too. This is entirely bespoke for you, it uses only your select research feeds. Information so shared is guaranteed secure, it is not used elsewhere, and not for any other purpose.
The online forecast Database provides access to the most up-to-date numbers and lets you look at how market expectations are changing over time. Compare companies, drugs,
pipeline development, results, valuation, discussion and more.
We have reported full-year and quarterly numbers for drug sales and P&L lines going back to 2000 as well as five-year forecasts. Excel and PDF downloads available.
DRUGANALYST DATA FEEDS
Why not use our forecast numbers in your models?
It's easy to consume our data by API, FTP drop or Excel Plugin. Access 3.7 million data points for 4,500 individual drugs and P&L lines with up to 15 years of historical data, reported numbers, and five-year forward forecasts.
We keep you on top of newsflow with our one-stop daily view of the sector. Coverage of all the major newsflow and what we're Thinking and Doing (T&Ds), in our signature independent style.
Some say it’s the only email you need to read!
Ahead of earnings
Our Pickers set out market expectations, catalysts and what we're looking for.
Our initial take on results
The beats, misses and critically, what drove it. Delivered shortly after the earnings release.
CUT & DRIED
Extensive post-telecon breakdown
Analysis of the numbers, newsflow, pipeline, guidance, risks, valuation and our BUY / SELL call.
PRICING & PAYMENTS
Our global BUY/SELL product for the entire database costs $70,000 p.a.
Due to the introduction of MiFIID pricing Europe, we provide sub-cuts of this data, whether on a stock by stock basis (£5,000 per stock), just for the European sector (£30,000), just Japanese coverage (£20,000) and even UK Pharma only (£10,000). Or any mix that you like. You can always ask.
Startups can negotiate further discounts.
172 Tottenham Court Road
London, W1T 7NS
We grant permission to quote the drug sales forecasts from this site provided they are accredited to: “DrugAnalyst - https://druganalyst.com/”
It looks like you're using a mobile device.
Would you like to go to the DRUGANALYST mobile site instead?